Search Results
Big data on efficacy and toxicity levels for ibrutinib in CLL
Real-world data on the effect of ibrutinib flexible dosing treatment strategies on TTNT in CLL/SLL
Dr. Wang on the Toxicity of Ibrutinib, Acalabrutinib, and Zanubrutinib in MCL
The safety and efficacy of ibrutinib for the treatment of CLL
Latest data with ONO-4059 and ibrutinib
Dr. Mato on Managing Side Effects With Ibrutinib/Idelalisib in CLL
CLL: Long-term updates on ibrutinib and idelalisib
Venetoclax: a lifesaving drug for CLL patients
Selecting between ibrutinib, acalabrutinib and zanubrutinib in the frontline setting in CLL
Enhancing immunotherapy for CLL patients with ibrutinib
What are the risks and benefits of both ibrutinib and Idelalisib?
The latest CLL treatments and therapies with Dr Jan Burger
